EYEPOINT PHARMACEUTICALS INC's ticker is EYPT and the CUSIP is 30233G209. A total of 86 filers reported holding EYEPOINT PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.23 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $27,892,459 | -23.5% | 3,490,921 | -16.7% | 24.59% | -10.9% |
| Q2 2023 | $36,461,013 | +195.9% | 4,190,921 | 0.0% | 27.59% | +287.1% |
| Q1 2023 | $12,321,308 | -16.0% | 4,190,921 | 0.0% | 7.13% | -12.8% |
| Q4 2022 | $14,668,224 | -55.8% | 4,190,921 | 0.0% | 8.18% | -40.3% |
| Q3 2022 | $33,150,000 | +0.5% | 4,190,921 | 0.0% | 13.70% | +0.5% |
| Q2 2022 | $32,983,000 | -35.2% | 4,190,921 | 0.0% | 13.63% | +10.7% |
| Q1 2022 | $50,920,000 | -0.7% | 4,190,921 | 0.0% | 12.31% | +6.7% |
| Q4 2021 | $51,297,000 | +17.5% | 4,190,921 | 0.0% | 11.54% | +19.1% |
| Q3 2021 | $43,669,000 | +15.9% | 4,190,921 | 0.0% | 9.69% | +74.1% |
| Q2 2021 | $37,676,000 | -11.5% | 4,190,921 | 0.0% | 5.56% | -16.4% |
| Q1 2021 | $42,580,000 | +54.4% | 4,190,921 | 0.0% | 6.66% | -7.0% |
| Q4 2020 | $27,576,000 | – | 4,190,921 | – | 7.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Essex Woodlands Management, Inc. | 4,190,921 | $36,461,013 | 27.59% |
| ACUTA CAPITAL PARTNERS, LLC | 382,000 | $3,323,400 | 2.25% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 3,423,897 | $29,787,904 | 1.59% |
| Cormorant Asset Management, LP | 3,200,000 | $27,840,000 | 1.56% |
| Caligan Partners LP | 310,298 | $2,699,593 | 1.52% |
| Samsara BioCapital, LLC | 432,000 | $3,758,400 | 0.66% |
| RA Capital Management | 3,370,506 | $29,323,402 | 0.55% |
| SECTORAL ASSET MANAGEMENT INC | 311,277 | $2,708,110 | 0.45% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 209,949 | $1,826,556 | 0.26% |
| BARD ASSOCIATES INC | 30,674 | $266,864 | 0.10% |